Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.

Autosomal Dominant Polycystic Kidney Disease Data Repository

Clinical Trial Details

Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease, affecting more than 500,000 people in the U.S. and 10 million people worldwide. ADPKD is the 4th most common cause of kidney failure requiring dialysis and/or transplantation. Over half of all ADPKD patients develop kidney failure by age 60 years, although age of onset of kidney disease varies widely, even among members of the same family.

The reason for creating this repository is to collect information about ADPKD so that we may fully understand its complications, including high blood pressure, kidney failure, stroke, and heart disease.

This information may also aid in the development of improved methods for diagnosis of ADPKD and strategies for treatment. If you join the research study, you will take part for as long as you wish to continue. About 500 people will take part in the research study.

You and others may provide benefit by the increased understanding that this information may give us about polycystic kidney disease. However, we cannot guarantee that you will benefit from this study.

There is no cost to you for being in this research study.

Eligibility:

  • Men and woman 18 or older
  • Diagnosed with ADPKD
  • Detailed eligibility provided when you contact the study team

For more information visit www.rogosin.org

Study contact by location

Upper East Side - Manhattan

Contact(s)

Ines G Chicos
(212) 746-3541
inc9012@nyp.org

Primary Investigator(s)

Protocol ID(s)

Weill Cornell Medicine IRB #:

0304006105

Status

Open to Enrollment

Sponsor